HARVARD BIOSCIENCE INC Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2011 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Harvard Bioscience Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2011 to Q1 2024.
  • Harvard Bioscience Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$1.06M, a 63.5% increase year-over-year.
  • Harvard Bioscience Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$12.1M, a 328% decline from 2022.
  • Harvard Bioscience Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$2.84M, a 1026% decline from 2021.
  • Harvard Bioscience Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$252K, a 96.8% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$1.06M +$1.84M +63.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q1 2023 -$2.89M -$2.99M -3178% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q1 2022 $94K +$3.24M Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q1 2021 -$3.14M +$1.93M +38.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 -$5.07M -$67K -1.34% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 -$5M -$56.2M -110% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $51.2M +$51.5M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 -$268K +$1.46M +84.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 -$1.73M -$2.56M -307% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q1 2015 $832K +$1.76M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q1 2014 -$931K -$4.53M -126% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q1 2013 $3.6M +$2.84M +370% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 $767K +$1.67M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 -$901K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.